more

HCA Healthcare (HCA)

(Delayed Data from NYSE)

$397.50 USD

-5.93 (-1.47%)

Updated Sep 17, 2024 04:00 PM ET

After-Market: $397.50 0.00 (0.00%) 6:10 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	23.68%
2	Buy	17.55%
3	Hold	9.21%
4	Sell	4.93%
5	Strong Sell	2.36%
S&P	500	10.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth F Momentum B VGM

Industry Rank:

Top 1% (3 out of 251)

Industry: Medical - Hospital

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Another Wild Week for Stocks as Coronavirus Fears Intensify

by David Borun Published on March 09,2020

Despite evidence that the virus is still not as bad as worst-case scenarios projected, fear is changing consumer and investor behavior in ways that may have lasting impact.

finance

Acadia Healthcare Gains From UK Unit Sale, Solid US Business

by Zacks Equity Research Published on March 03,2020

Acadia Healthcare (ACHC) is well poised for growth on several organic and inorganic growth efforts in U.S. business and the ongoing sale proceedings of U.K. operations.

medical

Magellan Health (MGLN) Q4 Earnings Beat Estimates, Rise Y/Y

by Zacks Equity Research Published on March 02,2020

Magellan Health's (MGLN) Q4 results reflect higher segment profit, partly offset by lower revenues.

medical

After a Brutal Week, Hopeful Investors Turn Their Eyes to the Fed

by David Borun Published on March 02,2020

The possibility of central bank action promise to lift equities after the biggest declines in over a decade.

finance

Acadia Healthcare (ACHC) Q4 Earnings Top Mark, Improve Y/Y

by Zacks Equity Research Published on February 28,2020

Acadia Healthcare's (ACHC) Q4 results reflect higher revenues, rise in patient days and lower expenses.

medical

HCA (HCA) Down 11.6% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research Published on February 27,2020

HCA (HCA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

HCANegative Net Change

Universal Health's (UHS) Q4 Earnings Surpass, Improve Y/Y

by Zacks Equity Research Published on February 27,2020

Universal Health's (UHS) Q4 results reflect higher revenues and solid segmental contributions.

medical

Teladoc (TDOC) Q4 Loss Narrower Than Expected, Revenues Beat

by Zacks Equity Research Published on February 27,2020

Teladoc's (TDOC) Q4 results reflect strong revenue growth, partially offset by high expenses.

Healthcare Sector to Remain Volatile in 2020 Amid Elections

by Sapna Bagaria Published on February 26,2020

Disparity in the regulatory policies of presidential candidates of various parties renders volatility to the healthcare sector.

medical

Tenet Healthcare (THC) Q4 Earnings Miss Estimates, Rise Y/Y

by Zacks Equity Research Published on February 25,2020

Tenet Healthcare's (THC) fourth-quarter results reflect improved performance of Ambulatory Care and Hospital segments, offset by poor performance of Conifer segment.

medical

Community Health (CYH) Hits 52-Week High on Solid Q4 Results

by Zacks Equity Research Published on February 24,2020

Community Health (CYH) reaches a 52-week high in Friday's trading session, backed by its strong fourth-quarter earnings performance.

medical

Community Health (CYH) Q4 Earnings Beat Estimates, Soar Y/Y

by Zacks Equity Research Published on February 20,2020

Community Health's (CYH) Q4 results benefit from lower operating costs and expenses, partially offset by soft revenues.

medical

3 Sector ETFs & Stocks to Win on Upbeat January Jobs Data

by Sanghamitra Saha Published on February 12,2020

Upbeat January jobs data should benefit these sector ETFs and stocks.

etfs

Trump Budget 2021 Likely to Impact These Sector ETFs

by Sanghamitra Saha Published on February 11,2020

President Donald Trump delivered his latest budget proposal for 2021 and out these ETFs in focus.

etfs

Virus Fears Dissipate and the Rally is Back On

by David Borun Published on February 10,2020

The deadly Coronavirus continues to claims new victims in China, but doesn't appear to be interfering with expectations for global growth

finance

HCA Healthcare (HCA) Q4 Earnings Beat Estimates, Rise Y/Y

by Zacks Equity Research Published on January 28,2020

HCA Healthcare's (HCA) Q4 results gain traction from better revenues and increased admissions.

medical

HCA Holdings (HCA) Tops Q4 Earnings and Revenue Estimates

by Zacks Equity Research Published on January 28,2020

HCA (HCA) delivered earnings and revenue surprises of 0.98% and 1.58%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?